يعرض 1 - 10 نتائج من 495 نتيجة بحث عن '"oxotremorine"', وقت الاستعلام: 0.79s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المساهمون: Scordino, Miriana, Frinchi, Monica, Urone, Giulia, Nuzzo, Domenico, Mudo, Giuseppa, Di Liberto, Valentina

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36978935; info:eu-repo/semantics/altIdentifier/wos/WOS:000952904100001; volume:12; issue:3; firstpage:1; lastpage:17; numberofpages:17; journal:ANTIOXIDANTS; https://hdl.handle.net/10447/590711Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85151371751; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045076Test/

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المساهمون: Frinchi M., Nuzzo D., Scaduto P., Di Carlo M., Massenti M.F., Belluardo N., Mudo G.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31578381; info:eu-repo/semantics/altIdentifier/wos/WOS:000488482200015; volume:9; issue:1; firstpage:14233; numberofpages:16; journal:SCIENTIFIC REPORTS; http://hdl.handle.net/10447/381270Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85072935560; www.nature.com/srep/index.html

  8. 8
    دورية أكاديمية

    المصدر: Pharmacy & Pharmacology; Том 7, № 2 (2019); 84-89 ; Фармация и фармакология; Том 7, № 2 (2019); 84-89 ; 2413-2241 ; 2307-9266 ; 10.19163/2307-9266-2019-7-2

    وصف الملف: application/pdf

    العلاقة: https://www.pharmpharm.ru/jour/article/view/363/528Test; https://www.pharmpharm.ru/jour/article/view/363/529Test; Schapira, A.H.V. Neurobiology and treatment of Parkinson’s disease. // Trends Pharmacol. Sci. – 2009. – Vol. 30(1). – P. 41–47. DOI:10.1016/j.tips.2008.10.005.; Marino, M.J, Conn, P.J. Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors. // Curr. Opin. Pharmacol. – 2006. – Vol. 6(1) – P. 98–102. DOI:10.1016/j.coph.2005.09.006.; Avdeeva, N.V., Nikitina, V.A., Kochkarova, I.S., Litvinova, A.S. The possibility of administration of glutamate receptors antagonists in the treatment of parkinson’s disease. // Research result: pharmacology and clinical pharmacology. – 2016. – Vol. 2(3). – Р. 86–94. DOI:10.18413/2500-235X-2016-2-3-86-94.; Avdeeva, N.V., Kulikov, A.L., Pokrovskii, M.V., Avtina, T.V. Pharmacokinetic studies of new antiparkinsonian drug Rapitalam. // Research result: pharmacology and clinical pharmacology. – 2016. – Vol. 2(4). – P. 3–8. DOI:10.18413/2500-235X-2016-2-4-3-8; Voronkov, A.V., Pozdnyakov, D.I. Endothelotropic activity of 4-hydroxy-3,5-di-tret-butylcinnamic acid in the conditions of experimental cerebral ischemia. // Research Results in Pharmacology. – 2018. – Vol. 4 (2). – Р. 1–10. DOI:10.3897/rrpharmacology.4.26519; Corti, C., Aldegheri, L., Somogyi, P., Ferraguti, F. Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS. // Neuroscience. – 2002. – Vol. 110(3). – Р. 403–420. DOI:10.1016/S0306-4522(01)00591-7; Marino, M.J., Hess, J.F., Liverton, N. Targeting the metabotropic glutamate receptor mGluR4 for the treatment of diseases of the central nervous system. // Curr. Top. Med. Chem. – 2005. – Vol. 5(9). – Р. 885–895. DOI:10.2174/1568026054750263; Yang, Z.Q. Agonists and antagonists for group III metabotropic glutamate receptors 6, 7, and 8. // Curr. Top. Med. Chem. – 2005. – Vol. 5(9). – Р. 913–918. DOI:10.2174/1568026054750272; Johnson, K. A., Conn, P. J., and Niswender, C. M. Glutamate receptors astherapeutic targets for Parkinson’s disease. // CNS and Neurological Disorders. – 2009. – Vol. 8(6). – Р. 475–491. DOI:10.2174/187152709789824606; Hopkins, C.R., Lindsley, C.W., Niswender, C.M. mGluR4-positive allosteric modulation as potential treatment for Parkinson’s disease. // Future Med Chem. – 2009. – Vol. 1(3). – Р. 501–513. DOI:10.4155/fmc.09.38.mGluR4-positive; Wichmann, T., DeLong, M.R. Functional neuroanatomy of the basal ganglia in Parkinson’s disease. // Adv. Neurol. – 2003. – Vol. 91. – Р. 9–18.; Авдеева. Н.В., Сидорова. С.А., Поветкин. С.В., и др. Позитивная аллостерическая модуляция рецепторов mGluR4 как потенциальный подход к лечению болезни Паркинсона. // Известия высших учебных заведений. Медицинские науки. – 2018. – № 3. – С. 194–206.; Boraud, T., Bezard, E., Bioulac, B., Gross, C.E. From single extracellular unit recording in experimental and human parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control. // Prog. Neurobiol. – 2002. – Vol. 66(4). – Р. 265–283. DOI:10.1016/S0301-0082(01)00033-8; Conn, P,J., Pin, J.P.,. Pharmacology and functions of metabotropic glutamate receptors. // Ann. Rev. Pharmacol. Toxicol. – 1997. DOI: 37:205–237.10.1146/annurev.pharmtox.37.1.205; Dauer, W., Predborski, S. Parkinson’s disease: mechanisms and models. // Neuron. – 2003. – Vol. 39(6). – Р. 889–909. DOI:10.1016/S0896-6273(03)00568-3; Электронный ресурс, лекции белорусского государственного медицинского университета. https://studfiles.net/preview/6011051Test/; Pisani, A., Bernardi, G., Ding, J., Surmeier, D.J. Re-emergence of striatal cholinergic interneurons in movement disorders. // Trends Neurosci. – 2007. – Vol. 30. – Р. 545–553. DOI:10.1016/j.tins.2007.07.008; DiChiara, G., Morelli, M., Consolo, S. Modulatory functions of neurotransmitters in the striatum: ACh/ dopamine/NMDA interactions. // Trends Neurosci. – 1994. – Vol. 17(6). – Р. 228–233. DOI:10.1016/0166-2236(94)90005-1; Lester, D.B., Rogers, T.D., Blaha, C.D. Acetylcholinedopamine interactions in the pathophysiology and treatment of CNS disorders. // CNS Neurosci Ther. – 2010. – Vol. 16(13). – Р. 137–162. DOI:10.1111/j.1755-5949.2010.00142.x; https://www.pharmpharm.ru/jour/article/view/363Test

    الإتاحة: https://doi.org/10.19163/2307-9266-2019-7-2-84-8910.19163/2307-9266-2019-7-210.1016/j.tips.2008.10.00510.1016/j.coph.2005.09.00610.18413/2500-235X-2016-2-3-86-9410.18413/2500-235X-2016-2-4-3-810.3897/rrpharmacology.4.2651910.1016/S0306-4522Test(01)00591-710.2174/156802605475026310.2174/156802605475027210.2174/18715270978982460610.4155/fmc.09.38.mGluR4-positive10.1016/S0301-0082(01)00033-810.1016/S0896-6273(03)00568-310.1016/j.tins.2007.07.00810.1016/0166-2236(94)90005-110.1111/j.1755-5949.2010.00142.x
    https://www.pharmpharm.ru/jour/article/view/363Test

  9. 9
    دورية أكاديمية

    المؤلفون: Avdeeva, N. V.

    العلاقة: Avdeeva, N.V. Study of rapitalam influence on oxotremorine-induced tremor / N.V. Avdeeva // Фармация и фармакология. - 2019. - Т.7, №2.-P. 84-89.; http://dspace.bsu.edu.ru/handle/123456789/31810Test

  10. 10